Fact CheckerSign in

NCT07292389Recruiting

Examining Valence-based Effects in Self-Monitoring Feedback Messages

Examining Valence-based Effects in Self-monitoring Feedback Messages, in the Development of a Novel Semi-automated Self-monitoring Feedback System for Obesity Treatment

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

The purpose of this research study is to learn how to identify the most effective ways to provide weekly feedback on participants' progress toward intervention goals during a weight loss program.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
127 (estimated)
First submitted
5 Dec 2025
Start date
23 Mar 2026
Primary completion date
May 2027
Lead sponsor
University of Virginia
Diseases
Obesity
NCT number
NCT07292389

What you commit to

  • Study type: Interventional
  • Planned participants: 127
  • From 23 Mar 2026 to the primary completion date, May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of weight loss medications, or use of weight loss medications in the 6 months prior to initial pre-screening
  • Weight loss of greater than or equal to 10 lbs in the 6 months prior to initial pre-screening
  • Recent (in the past 6 months) changes in medications that affect weight

Other illness

  • History of bariatric surgery or plans to obtain bariatric surgery during the study period
  • Lack of written confirmation that the potential participant has discussed study participation with their physician if they have been diagnosed with diabetes, hypertension, or has have a history of coronary heart disease
  • Medical conditions that contraindicate weight loss or prevent completion of the study (e.g., current diagnosis of cancer or terminal illness, dementia, etc.)
  • Self-reported eating disorder within past 5 years
  • Failure to complete baseline assessment measures
  • Failure to complete at least 4 out of 6 days of self-monitoring dietary and weight self-monitoring during the behavioral run-in period
  • Any other condition(s) which, in the opinion of the Principal Investigator, would adversely affect participation in the study

Other

  • Weight greater than 175 kg (due to a weight limit of the study-provided scale)
  • Smartphone device owned deemed incompatible with the Fitbit App
  • Currently participating in a weight-loss program
  • Physical limitations that prevent walking at a brisk pace for at least 10 minutes without stopping
  • Use of a pacemaker or other implanted medical device
  • Currently pregnant
  • Currently breastfeeding
  • Less than 1-year post-partum
  • Plans to become pregnant within the study period
  • One or more study participants living in the household (enrollment limited to one participant per household)
  • Unable to complete the 17-week study (due to plans to relocate during the study period, etc.)
  • Unable or unwilling to provide informed consent
  • Unable to read English at the 5th grade level
  • Unwilling to accept random assignment
  • Unable or unwilling to download the study smartphone application, wear the physical activity monitor, or use the study e-scale

Who the study is looking for

  • Age greater than or equal to 18 years
  • BMI greater than or equal to 25.0 kg/m2
  • Weight less than or equal to 175 kg (due to scale limit)
  • Own a smartphone compatible with Fitbit (e.g., an Apple iPhone running iOS 16.4 or higher or Android smartphone running Android 11 or higher) with a cellular and data plan

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Virginia
Coordinator of this site? Confirm its status
CharlottesvilleUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.